Patents by Inventor Stefano Gustincich

Stefano Gustincich has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230383293
    Abstract: The invention relates to functional nucleic acid molecules comprising a target determinant sequence and a regulatory sequence wherein the functional nucleic acid molecule comprises one or more chemical modifications, particularly for use in methods of increasing target protein synthesis efficiency.
    Type: Application
    Filed: September 24, 2021
    Publication date: November 30, 2023
    Applicants: FONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIA, SCUOLA INTERNAZIONALE SUPERIORE DI STUDI AVANZATI, TRANSINE THERAPEUTICS LIMITED
    Inventors: Piero CARNINCI, Hazuki TAKAHASHI, Naoko TOKI, Stefano GUSTINCICH, Bianca PIERATTINI, Paola VALENTINI
  • Patent number: 11649456
    Abstract: There is disclosed a trans-acting functional nucleic acid molecule comprising a eukaryotic target binding sequence comprising a sequence reverse complementary to a target mRNA sequence for which protein translation is to be enhanced, and a regulatory sequence comprising an internal ribosome entry site (IRES) sequence or an internal ribosome entry site (IRES) derived sequence and enhancing translation of the target mRNA sequence, wherein the regulatory sequence is located 3? of the target binding sequence.
    Type: Grant
    Filed: September 20, 2018
    Date of Patent: May 16, 2023
    Assignees: FONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIA, SCUOLA INTERNAZIONALE SUPERIORE DI STUDI AVANZATI
    Inventors: Stefano Gustincich, Silvia Zucchelli
  • Publication number: 20220259595
    Abstract: There are disclosed functional nucleic acid molecules comprising at least one target binding sequence comprising a sequence reverse complementary to a frataxin mRNA sequence; and a regulatory sequence comprising a SINE B2 element or a functionally active fragment of a SINE B2 element or an internal ribosome entry site (IRES) sequence or an IRES derived sequence.
    Type: Application
    Filed: July 10, 2020
    Publication date: August 18, 2022
    Inventors: Stefano Gustincich, Silvia Zucchelli (deceases), Carlotta Bon
  • Publication number: 20210139898
    Abstract: There are disclosed functional nucleic acid molecules comprising a target binding sequence comprising a sequence reverse complementary to a target mRNA sequence for which protein translation is to be enhanced; and a regulatory sequence having two-dimensional structures comprising specific stem-loop and internal loop domains and displaying translation enhancing efficiency.
    Type: Application
    Filed: February 5, 2019
    Publication date: May 13, 2021
    Applicants: Scuola Internazionale Superiore Di Studi Avanzati ? SISSA, TranSINE Therapeutics Limited
    Inventors: Stefano GUSTINCICH, Silvia ZUCCHELLI, Peter PODBEVSEK, Janez PLAVEC, Piero CARNINCI, Hazuki TAKAHASHI, Toshio YAMAZAKI, Takako OHYAMA, Harshita SHARMA
  • Publication number: 20200224197
    Abstract: There is disclosed a trans-acting functional nucleic acid molecule comprising a eukaryotic target binding sequence comprising a sequence reverse complementary to a target mRNA sequence for which protein translation is to be enhanced, and a regulatory sequence comprising an internal ribosome entry site (IRES) sequence or an internal ribosome entry site (IRES) derived sequence and enhancing translation of the target mRNA sequence, wherein the regulatory sequence is located 3? of the target binding sequence.
    Type: Application
    Filed: September 20, 2018
    Publication date: July 16, 2020
    Applicants: FONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIA, SCUOLA INTERNAZIONALE SUPERIORE DI STUDI AVANZATI
    Inventors: Stefano GUSTINCICH, Silvia ZUCCHELLI
  • Patent number: 9353370
    Abstract: The present invention provides (a) a functional nucleic acid molecule comprises: a target determinant sequence comprising antisense sequence to a target sequence in the protein-encoding RNA for which protein synthesis efficiency is to be increased and a regulatory sequence having an activity of increasing of the protein synthesis efficiency, and (b) a use of the functional nucleic acid molecule.
    Type: Grant
    Filed: March 30, 2012
    Date of Patent: May 31, 2016
    Assignees: Riken, International School for Advanced Studies
    Inventors: Piero Carninci, Alistair Forrest, Stefano Gustincich, Claudia Carrieri, Silvia Zucchelli
  • Publication number: 20140107187
    Abstract: The present invention provides (a) a functional nucleic acid molecule comprises: a target determinant sequence comprising antisense sequence to a target sequence in the protein-encoding RNA for which protein synthesis efficiency is to be increased and a regulatory sequence having an activity of increasing of the protein synthesis efficiency, and (b) a use of the functional nucleic acid molecule.
    Type: Application
    Filed: March 30, 2012
    Publication date: April 17, 2014
    Applicants: INTERNATIONAL SCHOOL FOR ADVANCED STUDIES, RIKEN
    Inventors: Piero Carninci, Alistair Forrest, Stefano Gustincich, Claudia Carrieri, Silvia Zucchelli